NEW WARNING: Uterine sarcoma linked with long-term tamoxifen use


Cases of uterine sarcoma in women receiving tamoxifen citrate (Nolvadex, AstraZeneca) have prompted a "Dear Health Professional" letter, black-box warnings on labeling, and publication of a letter to the editor in the New England Journal of Medicine from FDA officials.

© 2023 MJH Life Sciences

All rights reserved.